Intradermal immunization with ovalbumin-loaded poly-ε-caprolactone microparticles conferred protection in ovalbumin-sensitized allergic mice

Clinical and Experimental Allergy

Volumn 37, Issue 2, 2007, Pages 287-295

  Roman, B S ^a   Espuelas, S ^a   Gomez S ^a   Gamazo, C ^a   Sanz, M L ^b   Ferrer, M ^b   Irache, J M ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Adjuvant; Allergy; Immune response; Microparticles; Ovalbumin

Indexed keywords

ALLERGEN; ALUMINUM HYDROXIDE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; OVALBUMIN; POLYCAPROLACTONE;

ALLERGY; ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DESENSITIZATION; FEMALE; HUMORAL IMMUNITY; IMMUNOTHERAPY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; SURVIVAL; TH2 CELL;

ALLERGENS; ANAPHYLAXIS; ANIMALS; DRUG ADMINISTRATION ROUTES; HUMANS; IMMUNE TOLERANCE; MICE; OVALBUMIN; TH2 CELLS;

EID: 33846417597     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02654.x     Document Type: Article

References (35)

1. + T cells from allergic individuals. J Exp Med 1993; 178:2123-30.
2. Bousquet J, Becker WM, Hejjaoui A et al. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. J Allergy Clin Immunol 1991; 88:43-53.
3. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. AWHO position paper. J Allergy Clin Immunol 1998; 102:558-62.
4. Clemmensen O, Knudsen HE. Contact sensitivity to aluminium in a patient hyposensitized with aluminium precipitated grass pollen. Contact Dermatitis 1980; 6:305-8.
5. Vogelbruch M, Nuss B, Korner M, Kapp A, Kiehl P, Bohm W. Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations. Allergy 2000; 55:883-7.
6. Williams AP, Krishna MT, Frew AJ. The safety of immunotherapy. Clin Exp Allergy 2004; 34:513-4.
7. Edwards PE. Asthma management at the source. Case Manager 2004; 15:59-61.
8. Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release 2003; 90:261-80.
9. Reddy LH. Drug delivery to tumours: recent strategies. J Pharm Pharmacol 2005; 57:1231-42.
10. Scholl I, Weissenbock A, Forster-Waldl E et al. Allergen-loaded biodegradable poly(D,L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model. Clin Exp Allergy 2004; 34:315-21.
11. Batanero E, Barral P, Villalba M, Rodriguez R. Encapsulation of Ole e 1 in biodegradable microparticles induces Th1 response in mice: a potential vaccine for allergy. J Control Release 2003; 92:395-8.
12. Lemoine D, Francois C, Kedzierewicz F, Preat V, Hoffman M, Maincent P. Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). Biomaterials 1996; 17:2191-97.
13. Jameela SR, Suma N, Jayakrishnan A. Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study. J Biomater Sci Polym Ed 1997; 8:457-66.
14. Murillo M, Grillo MJ, Rene J et al. A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice. Vaccine 2001; 19:4099-106.
15. del Barrio GG, Novo FJ, Irache JM. Loading of plasmid DNA into PLGA microparticles using TROMS (total recirculation one-machine system): evaluation of its integrity and controlled release properties. J Control Release 2003; 86:123-30.
16. Estevan M, Gamazo C, Gonzalez-Gaitano G, Irache JM. Optimization of the entrapment of bacterial cell envelope extracts into microparticles for vaccine delivery. J Microencapsul 2006; 23:169-81.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
18. Fairbanks G, Steck TL, Wallach DF. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 1971; 10:2606-17.
19. Oakley BR, Kirsch DR, Morris NR. A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem 1980; 105:361-3.
20. Gamazo C, Winter AJ, Moriyon I, Riezu-Boj JI, Blasco JM, Diaz R. Comparative analyses of proteins extracted by hot saline or released spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis. Infect Immun 1989; 57:1419-26.
21. Faquim-Mauro EL, Macedo MS. Induction of IL-4-dependent, anaphylactic-type and IL-4-independent, non-anaphylactic-type IgG1 antibodies is modulated by adjuvants. Int Immunol 2000; 12:1733-40.
22. Steerenberg PA, van Dalen WJ, Withagen CE, Dormans JA, van Loveren H. Optimization of route of administration for coexposure to ovalbumin and particle matter to induce adjuvant activity in respiratory allergy in the mouse. Inhal Toxicol 2003; 15:1309-25.
23. Castillo JG, Gamboa PM, Oehling A, Wong E, de la Cuesta CG. Variations in antigen-specific histamine release related with immunotherapeutic treatment. Allergol Immunopathol (Madrid) 1989; 17:149-53.
24. Watanabe N, Matsuda E, Masuda A, Nariai K, Shibasaki T. The effects of fexofenadine on eosinophilia and systemic anaphylaxis in mice infected with Trichinella spiralis. Int Immunopharmacol 2004; 4:367-75.
25. Li XM, Schofield BH, Huang CK, Kleiner GI, Sampson HA. A murine model of IgE-mediated cow's milk hypersensitivity. J Allergy Clin Immunol 1999; 103:206-14.
26. Poulsen OM, Hau J, Kollerup J. Effect of homogenization and pasteurization on the allergenicity of bovine milk analysed by a murine anaphylactic shock model. Clin Allergy 1987; 17:449-58.
27. Jones DH, McBride BW, Jeffery H, O'Hagan DT, Robinson A, Farrar GH. Protection of mice from Bordetella pertussis respiratory infection using microencapsulated pertussis fimbriae. Vaccine 1995; 13:675-81.
28. Maloy KJ, Donachie AM, O'Hagan DT, Mowat AM. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology 1994; 81:661-7.
29. Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan - DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999; 5:387-91.
30. Benoit MA, Baras B, Gillard J. Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery. Int J Pharm 1999; 184:73-84.
31. Slobbe L, Medlicott N, Lockhart E et al. A prolonged immune response to antigen delivered in poly (epsilon-caprolactone) microparticles. Immunol Cell Biol 2003; 81:185-91.
32. Uchida T, Martin S, Foster TP, Wardley RC, Grimm S. Dose and load studies for subcutaneous and oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin. Pharm Res 1994; 11:1009-15.
33. Malling HJ, Dreborg S, Weeke B. Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side-effects of immunotherapy with Cladosporium herbarum. Allergy 1986; 41:507-19.
34. Kagi MK, Wuthrich B. Different methods of local allergen-specific immunotherapy. Allergy 2002; 57:379-88.
35. Vrtala S, Ball T, Spitzauer S et al. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation. J Immunol 1998; 160:6137-44.